相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia
Aikaterini Gkoufa et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta
Jean-Jacques Rouby et al.
ANNALS OF INTENSIVE CARE (2022)
Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials
Antoine Monsel et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2021)
COVID-19 and Antimicrobial Resistance: Data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance-WHONET-Greece (January 2018-March 2021)
Michalis Polemis et al.
LIFE-BASEL (2021)
Aerosol delivery via invasive ventilation: a narrative review
Hui-Ling Lin et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
J. J. Rouby et al.
INTENSIVE CARE MEDICINE (2020)
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial
Michael S. Niederman et al.
LANCET INFECTIOUS DISEASES (2020)
The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation
Jean-Jacques Rouby et al.
ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2020)
Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks
Stefan Felix Ehrentraut et al.
MICROORGANISMS (2020)
International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
A mesh nebulizer is more effective than jet nebulizer to nebulize bronchodilators during non-invasive ventilation of subjects with COPD: A randomized controlled trial with radiolabeled aerosols
Valdecir Castor Galindo-Filho et al.
RESPIRATORY MEDICINE (2019)
Comparison of Salbutamol Delivery Efficiency for Jet versus Mesh Nebulizer Using Mice
Kyung Hwa Chang et al.
PHARMACEUTICS (2019)
Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies
Elizabeth T. Thomas et al.
BMJ OPEN (2019)
Nebulization of antimicrobial agents in mechanically ventilated adults in 2017: an international cross-sectional survey
Joana Alves et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Exploring colistin pharmacodynamics against Klebsiella pneumoniae: a need to revise current susceptibility breakpoints
Marilena Tsala et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients
Matthieu Boisson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients
Alan Forrest et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases
J. Rello et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia IASIS Trial
Marin H. Kollef et al.
CHEST (2017)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines
C. Sole-Lleonart et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate
Juan P. Horcajada et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
Sami Abdellatif et al.
ANNALS OF INTENSIVE CARE (2016)
The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia: A Systematic Review and Metaanalysis
Antonis Valachis et al.
CRITICAL CARE MEDICINE (2015)
Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients
Matthieu Boisson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?
Phillip J. Bergen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients
Zoe E. Athanassa et al.
INTENSIVE CARE MEDICINE (2012)
Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa
Qin Lu et al.
INTENSIVE CARE MEDICINE (2010)
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
Pinyo Rattanaumpawan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
F Ratjen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
A Michalopoulos et al.
CRITICAL CARE (2005)
Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
分享论文
